SCHEMBL19080082

SCHEMBL19080082

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5ccc6cc7c(cc6c5)oc5cc6ccccc6cc57)c5ccccc45)c4ccccc34)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.40
GPR84 Q9NQS5 1/20 0.40
MIF P14174 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
CYP1A2 P05177 3/20 0.34
CYP2C9 P11712 3/20 0.34
TSHR P16473 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C19 P33261 2/20 0.34
SOS1 Q07889 1/20 0.34
HIF1A Q16665 1/20 0.34
PRKDC P78527 1/20 0.34
CYP3A4 P08684 2/20 0.33
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19076494 0.95 AHR (0.38) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL22062783 0.94 GPR84 (0.39) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL20127571 0.94 GPR84 (0.39) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL16067731 0.94 GPR84 (0.39) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL19076491 0.94 MAOA (0.37) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL19080019 0.93 ESR1 (0.41) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL19080081 0.91 ABCG2 (0.37) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL20053302 0.91 ESR1 (0.38) GSTP1GPR84MIFCYP1A1CYP1B1
SCHEMBL22062641 0.91 HDAC4 (0.38) GSTP1GPR84MIFHDAC4HDAC2
SCHEMBL19080048 0.90 MCL1 (0.39) GSTP1GPR84HDAC4HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 GSTP1 1966/4885GPR84 2425/4885MIF 2417/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 GSTP1 1966/4885GPR84 2425/4885MIF 2417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.